Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy.
Miedouge
M
M
Laboratoire de Biologie Polyvalente, Hôpital Général 12027 Rodez Cedex 9, France.
Hacini
J
J
Grimont
F
F
Watine
J
J
D000328:Adult; D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000009:adverse effects*; D004927:Escherichia coli Infections / Q000175:diagnosis* / Q000188:drug therapy*; D019453:Escherichia coli O157 / Q000302:isolation & purification*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D007677:Kidney Function Tests; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects*; D011379:Prognosis; D018570:Risk Assessment; D014552:Urinary Tract Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D015242:Ofloxacin